Clinical Trial Update: To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update evaluates the therapeutic equivalence and safety of Tretinoin Cream 0.1% versus the reference listed drug for acne vulgaris. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Reference Listed Drug (RLD) for Tretinoin Cream, 0.1% (tretinoin)
• Tretinoin Cream, 0.1% (tretinoin)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | EARLY_Phase 1 | Status: COMPLETED